Chemi SpA (Chemi; Milan, Italy) has announced that its manufacturing facility, ITF Chemical Ltda, (ITF; Camacari, Bahia, Brazil) has been granted “acceptable status” after an inspection was conducted by HHS (Washington, DC) on its construction of new R&D and QC facilities.
Chemi SpA (Chemi; Milan, Italy) has announced that its manufacturing facility, ITF Chemical Ltda, (ITF; Camacari, Bahia, Brazil) has been granted “acceptable status” after an inspection was conducted by HHS (Washington, DC) on its construction of new R&D and QC facilities.
ITF, which specializes in the production of active pharmaceutical ingredients and nutraceutical ingredients, was notified of the new status on June 16. Its new facilities come as a result of increased production of SerinAid PhosphatidylSerine (PS), which is known in the United States as a product used to enhance skills like memory, concentration, and exercise performance. PS is supplied to the United States through Chemi’s U.S. supplier, Chemi Nutra (White Bear Lake, MN).
The Nutritional Outlook Podcast Episode 33: Keeping up with contract manufacturing
July 26th 2024Nutritional Outlook talks to Lauren Samot, commercial innovation leader, and Blayney McEneaney, sales executive at Vitaquest International, about trends within the contract manufacturing space, and the ways in which contract manufacturers like Vitaquest keep up with the market and differentiate themselves from the competition.